Grande Enhancement Serums
Allegations: Deceptively marketing products as cosmetics without warning that an ingredient in them may cause serious side effects
Grande Enhancement Serums
Case Name (Date)
Mandel et al. v. Grande Cosmetics, LLC
22-cv-71, N.D. Cal.
(Jan. 2022)
Product/Service
GrandeLASH-MD Lash Enhancing Serum, GrandeBROW Brow Enhancing Serum, and GrandeHAIR Enhancement Serum
Allegations
Misleadingly marketing products as safe cosmetics when they are actually drugs that contain an ingredient that poses serious health risks
Status
Pending
Class-Action Tracker
GrandeLASH-MD, GrandeBROW, and GrandeHAIR Serums
Allegations: Deceptively marketing products as safe cosmetics with no active drug ingredient and no serious side effects when the active ingredient in them is found in prescription drugs that grow…
The Latest
CATrends: Celebrities Deceptively Promoting Cryptoassets
A-listers face lawsuits over promotions of risky and unregulated investments.
DOJ Orders doTerra Distributors to Pay $15,000 Each after TINA.org Complaint
Complaints against additional distributors who hosted COVID webinars may be forthcoming.
MLMs Need to be Included in FTC’s Business Opportunity Rule
TINA.org files comment in support of applying rule to direct selling industry.
Call Me with Timothée Chalamet | Apple TV+
Even celebs have FOMO
Medical Mike’s CBD Oils
Don’t Be Like Mike and get an FDA/FTC warning letter regarding COVID claims.